Dr Tahlia Meola is an early career pharmaceutical scientist within the Clinical Pharmacology and Therapeutics Research Group at the University of South Australia. Her doctoral work focussed on developing innovative pharmaceutical formulations to overcome the challenges associated with the oral delivery of drugs, specifically to improve drug absorption to enable easier dosing regimens and improve patient compliance. Tahlia’s current research partners with pharmaceutical industry to explore rationale dosing regimens to optimise medicine use. Tahlia has extensive experience in early phase clinical trial conduct in accordance with regulatory standards, managing all aspects from study design to clinical trial reporting.
About me
Dr Tahlia Meola is an early career pharmaceutical scientist within the Clinical Pharmacology and Therapeutics Research Group at the University of South Australia. Her doctoral work focussed on developing innovative pharmaceutical formulations to overcome the challenges associated with the oral delivery of drugs, specifically to improve drug absorption to enable easier dosing regimens and improve patient compliance. Tahlia’s current research partners with pharmaceutical industry to explore rationale dosing regimens to optimise medicine use. Tahlia has extensive experience in early phase clinical trial conduct in accordance with regulatory standards, managing all aspects from study design to clinical trial reporting.
About me
Doctor of Philosophy University of South Australia
Bachelor of Biomedical Research (Honours) The University of South Australia
Bachelor of Pharmaceutical Science The University of South Australia
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2024 |
Open access
2
4
|
| 2024 |
Open access
|
| 2024 |
Open access
6
6
85
|
| 2024 |
Open access
|
| 2023 |
Open access
41
|
| 2022 |
Open access
5
4
7
|
| 2022 |
Open access
28
1
|
| 2021 |
Open access
27
25
4
|
| 2021 |
Open access
9
9
4
|
| 2021 |
Open access
4
4
5
|
| 2020 |
Open access
23
21
20
|
| 2020 |
11
11
3
|
| 2020 |
23
19
4
|
| 2020 |
Open access
7
7
|
| 2020 |
Open access
24
21
5
|
| 2020 |
Open access
46
44
8
|
| 2019 |
12
12
2
|
| 2019 |
Open access
91
84
4
|
| 2018 |
Open access
20
16
2
|
| Year | Output |
|---|---|
| 2024 |
|
| 2024 |
|
| 2024 |
|
| 2024 |
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Chalmers University of Technology | SWEDEN |
| Flinders University | AUSTRALIA |
| Healthy Care Services Pty Ltd | AUSTRALIA |
| Johnson & Johnson | UNITED STATES |
| Monash University | AUSTRALIA |
| National Human Genome Research Institute | UNITED STATES |
| Nazarbayev University | KAZAKHSTAN |
| Oulun Yliopisto | FINLAND |
| Pharmaceutical Society of Australia | AUSTRALIA |
| RDC Clinical Pty Ltd | AUSTRALIA |
| Tanunda Lutheran Home Inc | AUSTRALIA |
| University of Copenhagen | DENMARK |
| University of New South Wales | AUSTRALIA |
| University of Queensland | AUSTRALIA |
| University of South Australia | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
Education Committee MemberARC Centre of Excellence in Bio-Nano Science |
2018 |
MemberAustralian Nanotechnology Network (ANN) |
2018 |
Outreach Committee MemberARC Centre of Excellence in Bio-Nano Science |
2018 |
Education Committee MemberARC Centre of Excellence in Bio-Nano Science |
2017 |
MemberAustralian Nanotechnology Network (ANN) |
2017 |
Outreach Committee MemberARC Centre of Excellence in Bio-Nano Science |
2017 |
MemberRoyal Chemical Institute (RACI) |
2015 |
MemberRoyal Chemical Institute (RACI) |
2014 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Optimising treatment of haematological malignancies through the development of evidence-based dose individualisation strategies | Current |
